Park Medi World credit ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	FY26Mar 2026

	228
	−203
	0.11×
	−0.10×
	0.51×
	−0.46×
	6.48×
	9.8%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

PARKHOSPS₹221.25

Park Medi World Ltd.

· Pharma & Health

₹ CrorePeersMAXHEALTH FORTIS MEDANTA METROPOLIS MARKSANS RUBICON JLHL SHILPAMEDMcap ₹9,556 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

	Ratios — % unless marked × 12 Months Ending	FY26 31/03/2026
	Total Debt	227.9
	Net Debt	-203.5
	Total Debt/Equity	0.11
	Net Debt/Equity	-0.10
	Total Debt/EBITDA	0.51
	Net Debt/EBITDA	-0.46
	Interest Coverage (EBIT/Interest)	6.48
	Total Debt/Total Capital %	9.77

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.